Baker Bros., Mirati Therapeutics:
In a new form 4 from today, Julian and Felix Baker
's Baker Bros. Advisors reported buying 400,000 shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX
). Following the transaction, Baker Bros own an aggregate amount of some 2.4 million shares. The shares have been purchased in terms of an underwritten public offering of Mirati Therapeutics, the per-share price amounting to $17.5 apiece.
The 10 Main Hedge Fund Moves of the Past Seven Days
Weiss Asset Management Lowers Its Position in LSE-listed Tamar
Outerwall Listens to Jana — Should You?